A new test could make it easier to detect high-risk prostate cancer cases earlier. The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard ...

Developed by Grail Inc., the Galleri test analyzes fragments of circulating DNA in the bloodstream, searching for methylation patterns associated with cancer cells. Rather than looking for one ...

Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri ...

GRAND JUNCTION, Colo. (KJCT) - According to the American Cancer Society, more than 30,000 Coloradans are expected to be diagnosed with cancer this year. Now, a new blood test could help detect cancer ...

Scientists are developing a test that uses a tiny blood sample to detect pancreatic cancer in its early stages. If caught early, pancreatic cancer can potentially be treated. However, patients usually ...

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early on. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically ...

Add Yahoo as a preferred source to see more of our stories on Google. A new blood test detects pancreatic cancer in 65% of patients, up from 17% with the previous test. Northwestern Medicine ...

IRVING, Texas, July 1, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the ...

PHOENIX — What if artificial intelligence could help save your life? A retired Air Force pilot says that's exactly what happened to him. After seeing fellow service members develop cancer and other ...

June 30 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has approved Orca Bio's therapy for the treatment of ‌certain blood cancers, which also aims to lower the risk of stem cell ...

Investors have waited with varying levels of patience for multi-cancer screening tests to lift off toward a targeted $30 billion to $50 billion in annual volume. Sales this year from the blood tests ...

Would you plant a chip in your brain if it promised to detect or even prevent cancer? Three people agreed to do just that. San Francisco-based longevity company Coherence Neuro briefly placed an ...